Edwin Hertzog

Biography

Dr. Edwin Hertzog, Ph.D., has served as Non-Executive Chairman of Mediclinic International Plc since February 15, 2016. He was appointed as the Non-executive Chairman of the Company on 15 February 2016 upon the successful combination of the businesses of the Company (then Al Noor Hospitals Group plc) and Mediclinic International Limited. Prior to the combination, he served as a director of Mediclinic International Limited since 1983 and as the Chairman since 1992. As a specialist anaesthetist, he was commissioned by the then Rembrandt group (now Remgro) in 1983 to undertake a feasibility study on the establishment of a private hospital group, and three years later, in 1986, Mediclinic International Limited (then Mediclinic Corporation Limited) was listed on the JSE. He was appointed as the first Managing Director of Mediclinic International Limited upon its establishment in 1983. He served as executive Chairman of the company from 1992 until August 2012 when he retired from his executive role, but remained on the Board as non-executive Chairman. He also serves as the non-executive Deputy Chairman of Remgro and is a past non-executive director of the Distell, Total (SA) and Trans Hex groups; and is also a past Chairman of the Hospital Association of South Africa as well as the Council of Stellenbosch University. He holds M.B.Ch.B.; M.Med.; F.F.A. (SA); and Ph.D. (honoris causa). He is Chairman of the Clinical Performance and Sustainability Committee of the Company.

Research Interest

Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology Pharmaceutical Nanotechnology